What’s Hindering BRCA Testing? Cost, Access, and Awareness

The promise of “precision medicine” is that the right patient gets the right drug at the right time. But in the realm of breast cancer, the gateway to that precision—BRCA genetic testing—is currently functioning as a filter of privilege rather than a clinical standard. While guidelines have expanded and the cost of testing has plummeted, … Read more

Colorectal Cancer: Family Talk & Risk Reduction Trial

The launch of a new clinical trial by the Alliance for Clinical Trials in Oncology isn’t just another research initiative; it’s a direct response to the growing recognition that genetic predisposition plays a significant, and often underestimated, role in colorectal cancer. As screening rates plateau and the incidence of early-onset colorectal cancer continues to rise … Read more